Therapeutic escape in gaq-mutant uveal melanoma: It's a FAK

Research output: Contribution to journalArticlepeer-review

Abstract

Through a synthetic lethal screen, ERK activation was found to mediate resistance to FAK inhibition in GNAQ-mutant uveal melanoma. With PLCB-PKC-ERK and Trio-FAK-Yap representing compensatory effectors of mutant Gaq signaling, combined inhibition of both pathways may be a promising therapeutic strategy in metastatic uveal melanoma.

Original languageEnglish (US)
Pages (from-to)2967-2969
Number of pages3
JournalClinical Cancer Research
Volume27
Issue number11
DOIs
StatePublished - Jun 1 2021
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Therapeutic escape in gaq-mutant uveal melanoma: It's a FAK'. Together they form a unique fingerprint.

Cite this